Tag: the-lifesaving
-
Mylan to pay $465 million over EpiPen Medicaid rebate dispute
Mylan NV on Friday said it will pay $465 million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, which has come under intense scrutiny after a series of drastic price increases. Mylan has been lambasted by consumers and lawmakers for raising prices on the lifesaving…
-
Mylan pays $465 million to settle EpiPen Medicaid rebate dispute
(Reuters) – Mylan NV on Friday said it will pay $465 million to settle the question of whether misclassification of its EpiPen emergency allergy treatment resulted in underpayment of rebates to the U.S. Medicaid healthcare program. The company has come under scrutiny for raising prices on the lifesaving EpiPen sixfold in less than a decade,…